Tevogen Inc.
TVGN· Nasdaq
TVGNTevogen Inc.
Filed Mar 31, 2026 · 10-K · 90 days after period end · 0001493152-26-014326
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$4.68M | -$9.44M | -$3.63M | $2.61M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 31, 2026 · 90 d after period end
